TRIM44 and metastatic malignant neoplasm in the lymph nodes: We also demonstrate for the first time that increased expression of TRIM44 is associated with poor differentiation, advanced pTNM stage, adenocarcinoma subtype, lymph node metastasis and, most importantly, poor survival.